QT
INO icon

Quantamental Technologies’s Inovio Pharmaceuticals INO Stock Holding History

Quantamental Technologies’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-750
Closed -$18K – 858
2019
Q3 		$18K Hold
750
– – 0.01% 1224
2019
Q2 		$26K Hold
750
– – 0.01% 1084
2019
Q1 		$34K Sell
750
-150
-17% -$7.56K 0.02% 962
2018
Q4 		$43K Buy
+900
New +$54.7K 0.03% 815

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantamental Technologies's INO Position: Q4 2019 in Review

Quantamental Technologies sold out of Inovio Pharmaceuticals (INO) in Q4 2019, closing a stake of 750 shares — an estimated $18K sold.

Quantamental Technologies first reported a position in INO in Q4 2018 and held it in 4 quarters. The position peaked at $43K in Q4 2018. 106 funds tracked by Wall St. Rank hold INO as of Q4 2019.

  • Quantamental Technologies reported no remaining Inovio Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 750 Inovio Pharmaceuticals shares in Q4 2019, an estimated $18K.
  • Quantamental Technologies first reported a position in Inovio Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Inovio Pharmaceuticals position peaked at $43K in Q4 2018.
  • 106 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.